COPD trials in Saudi Arabia

5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo

  Where

  Abhā, Riyadh

  Age

  30 years to 80 years

  People

  1,400 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07069829
• Phase 4Taking people
  A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

  Where

  Riyadh

  Age

  40 years to 85 years

  People

  218 worldwide

  Run by

  Sanofi

  See details and how to joinNCT07053423
• Phase 3Taking people
  Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

  Where

  Jeddah, Riyadh

  Age

  40 years to 80 years

  People

  942 worldwide

  Run by

  Sanofi

  See details and how to joinNCT07190209 · EU 2024-518016-39-00
• No phaseTaking people
  Assess Accuracy of Primary Care Asthma and COPD Diagnosis Using Oscillometry and FeNO vs Specialist Diagnosis

  Where

  Riyadh

  Age

  18 years and over

  People

  600 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07245576
• No phaseNot yet taking people in Saudi Arabia
  ECHO-COPD: Impact of a Pharmacist-Led Health Belief Model-Based Educational Intervention Among Chronic Obstructive Pulmonary Disease Patients

  Where

  Buraidah

  Age

  18 years to 65 years

  People

  140

  Run by

  Rabia Hussain

  See details and how to joinNCT07815353